Halcyon Senior Secured

A-

Halcyon BioSciences Ltd · Healthcare / Life Sciences

Commitment

£120m

Drawn

£47m

LTV

38%

Maturity

2031-09

Lead

Marcus L.

Covenants

Covenant

Threshold

Current

Status

Net Leverage Ratio

≤ 3.0x

1.9x

Compliant

Minimum Cash Balance

≥ £10m

£34m

Compliant

Documents

📄

Credit Memo — Halcyon Initial.pdf

Marcus Lund · 2024-09-15

📊

Financial Model v4.0.xlsx

Valentina Russo · 2026-02-22

Drawdown History

£25m2025-05-19

Phase III clinical trial funding

Approved by Marcus Lund

£22m2025-09-11

Manufacturing facility expansion

Approved by Oliver Brennan

Audit Log

Valentina Russo31 Mar 2026, 09:45

Covenant test filed — all covenants significantly within threshold